U.S. Food and Drug Administration Approved the HIV Diagnostic Tool

ArsitekturT Abbott HIV Ag / Ab Combo assay is the first diagnostic tool that is approved in the United States that can simultaneously detect both HIV antigen and antibody. HIV antigens are proteins produced by the virus soon after infection, while antibodies developed in the next day as the body works to fight infection. Just as would Stomach Circumference and Risk Diabetes research has shown that Abbott's new test can detect HIV earlier than previous antibody testing, and most important in controlling the spread of the virus, as can be detected early and the health of an infected person can also be controlled for counseling.

"Because people are most contagious to others soon after infection, early detection of HIV and save lives," said Peter Leone, MD, medical director, North Carolina HIV / STD Prevention and Control Branch, University of North Carolina, Chapel Hil. "A large number of new HIV infections are transmitted by a person with acute infection is detected, so the more people identify the previous offer significant opportunities for counseling, which can reduce high risk behavior and also make antiretroviral treatment for early stages of infection, if necessary."

Research conducted by the Center for Disease Control and Prevention / Centers for Disease Control and Prevention (CDC) showed that antibody testing is only now losing up to 10 percent of HIV infections in some high-risk population because they do not detect the antigen. However, a new test to detect HIV p24 antigen Abbott, or the direct presence of HIV, which allows for early diagnosis of infection before antibodies appear.

"Abbott has long been a pioneer in HIV testing from the world's first test to detect HIV antibodies in 1985 to second-and third-generation immunoassay and molecular tests and is now developing the country's first antigen and the antibody test combinations," said Brian Blaser, vice senior president, Diagnostics, Abbott. "Abbott is committed to fighting HIV and tests to help patients get the care they need as quickly as possible."

New tests will run on Abbott's Architect family of diagnostic testing instruments. It is already approved for use outside the United States. In Europe, the HIV antigen - antibody combinations of routine testing in public health settings and guidelines for HIV testing in the United Kingdom doctors are now directly use the combination of HIV testing as first-line test.Visit More : www.Goloox.com